5Hainsworth JD,Burris HA,Erland JB,et al.Phase I study of docetaxol administered by weekly infusion inpatients with advanced refractory cancer[J].J Clic Oncol,1998,16(6):2164-2168. 被引量：1
6Lee SH,Kang WK,Park J,et al.Combination chemotherapy with epirubicin,docetaxel and cisplatin (EDP) in metastatic or recurrent,unresectable gastric cancer[J].Br J Cancer.2004,91(1):18-22. 被引量：1
7Ajani JA.Docetaxel for gastric and esophageal carcinomas[J].Oncology.2002,16(Suppl 6):89-96. 被引量：1
8Ajani JA,Van Cutsem E,Moisey NV,et al.Docetaxel (D),cisplatin,5 fluorouracil compare to cisplatin (C) 5 fluorouracil (F) for chemotherapy paive patients iwth metastatic or locally recurrent,unresectable gastric carcinoma (MGC):Interin results of a randomized phase Ⅲ trial (V325)[J].Proc Am Soc Clin Oncol,2003,22:249 (abstra 999). 被引量：1
